hydrazine has been researched along with Hyperlipemia in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Aboelez, MO; Abuo-Rahma, GEA; Ahmed, SA; Elhady, OM; Shaykhon, MSA; Shoman, ME | 1 |
Ishino, S; Kuge, Y; Nishigori, K; Ogawa, Y; Ono, M; Saji, H; Shiomi, M; Takai, N; Temma, T | 1 |
Gobianand, K; Karthikeyan, S; Priya, S; Vijayalakshmi, P; Vivekanandan, P | 1 |
Abram, SR; Carter, C; Dearman, J; Hester, RL; Xiang, L | 1 |
4 other study(ies) available for hydrazine and Hyperlipemia
Article | Year |
---|---|
New nicotinic acid-based 3,5-diphenylpyrazoles: design, synthesis and antihyperlipidemic activity with potential NPC1L1 inhibitory activity.
Topics: Animals; Cholesterol; Drug Design; Hydrazines; Hyperlipidemias; Hypolipidemic Agents; Male; Membrane Transport Proteins; Molecular Docking Simulation; Nicotinic Acids; Pyrazoles; Rats, Wistar; Triglycerides | 2021 |
Tissue factor detection for selectively discriminating unstable plaques in an atherosclerotic rabbit model.
Topics: Animals; Antibodies, Monoclonal; Atherosclerosis; Autoradiography; Flow Cytometry; Hydrazines; Hyperlipidemias; Immunoglobulin G; Male; Molecular Probes; Nicotinic Acids; Rabbits; Radionuclide Imaging; Radiopharmaceuticals; Regression Analysis; Technetium Compounds; Thromboplastin; Tissue Distribution | 2010 |
Protective effect of picroliv against hydrazine-induced hyperlipidemia and hepatic steatosis in rats.
Topics: Adipose Tissue; Animals; Cholesterol; Cinnamates; Disease Models, Animal; Fatty Acids, Nonesterified; Fatty Liver; Glycosides; Hydrazines; Hyperlipidemias; Hypolipidemic Agents; Lipid Metabolism; Liver; Male; Phospholipids; Rats; Rats, Wistar; Triglycerides; Vanillic Acid | 2007 |
Insulin resistance and impaired functional vasodilation in obese Zucker rats.
Topics: Animals; Antioxidants; Arachidonic Acid; Arterioles; Blood Glucose; Bridged Bicyclo Compounds, Heterocyclic; Cyclic N-Oxides; Disease Models, Animal; Electric Stimulation; Fatty Acids, Unsaturated; Hydrazines; Hyperglycemia; Hyperlipidemias; Hypoglycemic Agents; Insulin; Insulin Resistance; Kidney Cortex; Male; Muscle, Skeletal; NADPH Oxidases; Obesity; Oxidative Stress; Rats; Rats, Zucker; Receptors, Thromboxane; Rosiglitazone; Spin Labels; Superoxides; Thiazolidinediones; Thromboxanes; Time Factors; Triglycerides; Vasoconstriction; Vasodilation | 2008 |